Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aleksei S. Kolbin"'
Autor:
Aleksei S. Kolbin, Dmitriy V. Vlodavets, Aleksei A. Kurylev, Olga Yu. Germanenko, Natalia Yu. Kolbina
Publikováno v:
Педиатрическая фармакология, Vol 18, Iss 5, Pp 408-415 (2021)
Background. Studies of the economic impact of disease on society or the social and economic burden, known as developmental disease cost analysis, are equivalent to public health epidemiological studies. Spinal muscular atrophy (SMA) has significant s
Externí odkaz:
https://doaj.org/article/b3df8e346e1341819c2e8c264843decf
Autor:
Olga Yu. Germanenko, Aleksei S. Kolbin, Aleksei A. Kurylev, Dmitriy V. Vlodavets, Natalia Yu. Kolbina
Publikováno v:
Pediatričeskaâ Farmakologiâ, Vol 18, Iss 5, Pp 408-415 (2021)
Background. Studies of the economic impact of disease on society or the social and economic burden, known as developmental disease cost analysis, are equivalent to public health epidemiological studies. Spinal muscular atrophy (SMA) has significant s
Autor:
Olga A. Sykhovskaya, Maria A. Smirnova, Aleksei S. Kolbin, Elena V. Radchenko, Timofey L. Galankin
Publikováno v:
Reviews on Clinical Pharmacology and Drug Therapy. 16:19-32
Background. Partial agonists of α4b2 nicotinic acetylcholine receptors are the most effective treatment strategy for tobacco smoking cessation. They are able to alleviate withdrawal symptoms and to reduce smoking satisfaction. The aim of this study